Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above Fifty Day Moving Average – What’s Next?

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA)’s stock price passed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $1.21 and traded as high as $1.2990. Sonoma Pharmaceuticals shares last traded at $1.24, with a volume of 324,217 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of Sonoma Pharmaceuticals from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, August 21st. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Sonoma Pharmaceuticals Stock Performance

The firm has a market cap of $5.22 million, a price-to-earnings ratio of -1.20 and a beta of 1.31. The business has a fifty day simple moving average of $1.20 and a 200-day simple moving average of $1.61.

Sonoma Pharmaceuticals (NASDAQ:SNOA) last announced its quarterly earnings results on Tuesday, November 10th. The company reported $0.09 EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.19. The firm had revenue of $7.17 million for the quarter, compared to analyst estimates of $5.29 million. Sonoma Pharmaceuticals had a negative return on equity of 4.82% and a negative net margin of 7.65%.

About Sonoma Pharmaceuticals

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing and commercializing non-antibiotic and non-steroidal products for human and animal health. Its products are designed for applications including dermatology, wound care, eye care and veterinary treatment. The company’s product portfolio is based primarily on Microcyn technology, a stabilized hypochlorous acid solution intended to cleanse, debride and manage wounds and various skin conditions. Products marketed under the company’s brands have included Dermacyn, for wound and skin care, and Ocucyn, for ophthalmic care, along with veterinary products and other prescription and over-the-counter formulations.